PCAR
56
-5
AVGO
18
-9
DNB
74
-6
PDCO
29
2
DOV
65
-4
DVN
14
-6
MCHP
34
-2
GE
61
-3
FRT
41
-2
RSG
65
-3
NAVI
52
-2
MDLZ
32
-4
OMC
50
-16
IR
63
-3
SJM
9
-5
KSS
39
-7
RL
69
-4
MSI
72
-3
GD
41
-4
PPG
57
-3
PCAR
56
-5
AVGO
18
-9
DNB
74
-6
PDCO
29
2
DOV
65
-4
DVN
14
-6
MCHP
34
-2
GE
61
-3
FRT
41
-2
RSG
65
-3
NAVI
52
-2
MDLZ
32
-4
OMC
50
-16
IR
63
-3
SJM
9
-5
KSS
39
-7
RL
69
-4
MSI
72
-3
GD
41
-4
PPG
57
-3
Financhill
Back

Aspen Pharmacare Holdings 10K Form

Sell
25

APNHY
Aspen Pharmacare Holdings

Last Price:
9.47
Seasonality Move:
-0.11%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive APNHY News And Ratings

See the #1 stock for the next 7 days that we like better than APNHY

APNHY Financial Statistics

Sales & Book Value

Annual Sales: $2.39B
Cash Flow: $0
Price / Cash Flow: 112.73
Annual Sales: $10.14
Price / Book: 0.93

Profitability

EPS (TTM): 0.53080
Net Income (TTM): $235.78M
Gross Margin: $1.04B
Return on Equity: 5.16%
Return on Assets: 3.21%

Aspen Pharmacare Holdings Earnings Forecast

Key Aspen Pharmacare Holdings Financial Ratios

  • The Gross Profit Margin over the past 22 years for APNHY is 43.52%.
  • The Selling, General & Administrative Expenses for APNHY have been equal to 11.33% of Gross Profit Margin.
  • The Interest Expense is 50.57% of Operating Income.
  • The Net Earning history of APNHY is 9.85% of Total Revenues.
  • Per Share Earnings over the last 22 years have been positive in 12 years.

Aspen Pharmacare Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: APNHY
Website: aspenpharma.com

Debt

Debt-to-Equity Ratio: 0.42
Current Ratio: 1.81
Quick Ratio: 1.06

Price-to-Earnings

Trailing P/E Ratio: 17.89
Forward P/E Ratio: 0

APNHY Technical Analysis vs Fundamental Analysis

Sell
25
Aspen Pharmacare Holdings (APNHY) is a Sell

Is Aspen Pharmacare Holdings a Buy or a Sell?